Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 9
2016 5
2017 4
2018 4
2019 4
2020 7
2021 4
2022 5
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R. Saghari M, et al. Among authors: gal p. Clin Pharmacol Ther. 2022 May;111(5):1121-1132. doi: 10.1002/cpt.2539. Epub 2022 Mar 1. Clin Pharmacol Ther. 2022. PMID: 35092305 Free PMC article. Clinical Trial.
Letter to the Editor.
Hassing GJ, Kemme MJB, Gal P. Hassing GJ, et al. Among authors: gal p. Ann Noninvasive Electrocardiol. 2020 Mar;25(2):e12755. doi: 10.1111/anec.12755. Epub 2020 Mar 3. Ann Noninvasive Electrocardiol. 2020. PMID: 32125055 Free PMC article. No abstract available.
Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers.
Bolognani F, Kruithof AC, Schulthess P, Machacek M, de Kam ML, Bergmann KR, van Gent M, Moerland M, Crenn P, Greig G, Gal P. Bolognani F, et al. Among authors: gal p. J Pharmacol Exp Ther. 2023 Aug;386(2):129-137. doi: 10.1124/jpet.123.001582. Epub 2023 Jun 14. J Pharmacol Exp Ther. 2023. PMID: 37316329 Clinical Trial.
Erythropoietin on cycling performance - Authors' reply.
Heuberger JAAC, Rotmans JI, Gal P, Stuurman FE, Daniels JMA, de Kam ML, Cohen AF. Heuberger JAAC, et al. Among authors: gal p. Lancet Haematol. 2017 Oct;4(10):e462-e464. doi: 10.1016/S2352-3026(17)30181-3. Lancet Haematol. 2017. PMID: 28962681 No abstract available.
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
Böttcher M, Düngen HD, Corcea V, Donath F, Fuhr R, Gal P, Mikus G, Trenk D, Coenen M, Pires PV, Maschke C, Aliprantis AO, Besche N, Becker C. Böttcher M, et al. Among authors: gal p. Am J Cardiovasc Drugs. 2023 Mar;23(2):145-155. doi: 10.1007/s40256-022-00557-2. Epub 2023 Jan 12. Am J Cardiovasc Drugs. 2023. PMID: 36633816 Free PMC article. Clinical Trial.
46 results